Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restults of General Meeting and Class Meetings

26 Mar 2013 14:04

RNS Number : 9122A
Maven Income & Growth VCT 4 PLC
26 March 2013
 

Maven Income and Growth VCT 4 PLC

 

Results of Shareholder Meetings and Share Capital Consolidation

 

26 March 2013

 

This announcement is made by Maven Income and Growth VCT 4 PLC ("the Company") in connection with (i) the proposed consolidation of its share capital ("Share Consolidation") and (ii) the proposed merger of the Company with Ortus VCT PLC ("Ortus"), which will be completed pursuant to a scheme of reconstruction under Section 110 of the Insolvency Act 1986 whereby Ortus will transfer all of its assets and liabilities to the Company in consideration of shares being issued by the Company ("the Scheme"), details of which were contained in the Company's circular to shareholders ("Circular") and prospectus ("Prospectus") both dated 1 March 2013.

 

Results of the General Meeting and Class Meetings

 

The Board is pleased to announce that at the general meeting and class meetings of the Company held on 26 March 2013, the resolutions proposed in connection with the Share Consolidation and the Scheme and other matters, as set out in the Circular, were duly passed on a show of hands.

 

Details of the resolutions passed at the general meeting are as follows:

 

·; Resolution 1 to: (i) authorise the directors to allot shares pursuant to the share consolidation; (ii) redesignate each S ordinary share of 10p each ("S Shares") as an ordinary share of 10p each ("Ordinary Shares") and (iii) amend the articles of association of the Company to remove any reference to S Shares as a separate class of shares - 97.59% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 2 to: (i) approve the acquisition of all of the assets and liabilities of Ortus VCT PLC; (ii) amend the articles of association of the Company to provide for the rights attaching to, and the conversion of, C ordinary shares; (iii) authorise the directors to allot shares pursuant to the Scheme and (iv) authorise the buyback of deferred shares- 96.49% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 3 to approve a change to the investment policy as detailed in Part V of the Circular - 98.91% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 4 to: (i) authorise the directors to allot shares; (ii) disapply pre-emption rights and (iii) authorise the Company to make market purchases of shares - 98.74% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 5 to: (i) authorise the cancellation of the amount standing to the credit of the share premium account as at the date an order is made the court and (ii) authorise the cancellation of the amount standing to the credit of the capital redemption reserve as at the date an order is made the court - 100% of proxy votes received being in favour (or at the chairman's discretion).

The resolutions passed at the Ordinary Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the Ordinary Shares resulting therefrom - 97.06% and 97.06% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

The resolutions passed at the S Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the S Shares resulting therefrom - 81.80% and 81.80% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

A copy of the resolutions passed at the meetings will shortly be available for inspection on both the Company's website (www.mavencp.com) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

 

Share Consolidation

 

Pursuant to the Share Consolidation, 804,028new S Shares have been issued today to the holders of S Shares on the Company's register on 25 March 2013 (this being the record date for the Share Consolidation). Application has been made to the UK Listing Authority for such shares to be admitted to the premium segment of the Official List, which is expected to take place on 27 March 2013.

 

Pursuant to Resolution 1 which was passed at the general meeting, immediately following the admission of such new S Shares to the Official List, all the S Shares then in issue in the capital of the Company will be redesignated as Ordinary Shares on a ratio of one to one. As a result, following completion of the Share Consolidation, holders of S Shares will hold 1.1528 Ordinary Shares for every S Share held on the record date for the Share Consolidation.

 

Applications will be made to the UK Listing Authority and London Stock Exchange in connection with the listing and admission of the new Ordinary Shares resulting from the Share Consolidation (and cancellation of the S Shares listing) which is expected to take effect on 28 March 2013. CREST accounts of shareholders who hold their Shares in CREST are expected to be updated and re-credited by 28 March 2013, with replacement share certificates dispatched to those who hold their share in certificated form expected to take place on 10 April 2013.

 

Following completion of the Share Consolidation, 15,225,880 Shares will be in issue. Therefore, the total number of voting rights in the Company will be 15,225,880, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

For further enquiries please contact:

 

Maven Capital Partners UK LLP

0141 306 7400

enquries@mavencp.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDKAEDDEFF
Date   Source Headline
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.